Literature DB >> 11189686

Design and evolution of the data management systems in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

M A Hasson1, R M Fagerstrom, D C Kahane, J H Walsh, M H Myers, C Caughman, B Wenzel, J C Haralson, L M Flickinger, L M Turner.   

Abstract

This paper describes the design and evolution of the data management systems developed in support of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. These systems span platforms from stand-alone computers to distributed systems on local area networks to mainframes. Allowing all of these systems to share appropriate information electronically introduces integration, synchronization, testing, and support challenges. For each platform, applications were developed to handle data entry, editing, trial management, reporting, telecommunications, and data sharing. Approaches to issues such as level of data access, integration with other, existing applications, and handling the expansion of the protocol are discussed.

Entities:  

Mesh:

Year:  2000        PMID: 11189686     DOI: 10.1016/s0197-2456(00)00100-8

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  8 in total

Review 1.  Ovarian cancer screening.

Authors:  Usha Menon
Journal:  CMAJ       Date:  2004-08-17       Impact factor: 8.262

2.  Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.

Authors:  Daniel W Cramer; Robert C Bast; Christine D Berg; Eleftherios P Diamandis; Andrew K Godwin; Patricia Hartge; Anna E Lokshin; Karen H Lu; Martin W McIntosh; Gil Mor; Christos Patriotis; Paul F Pinsky; Mark D Thornquist; Nathalie Scholler; Steven J Skates; Patrick M Sluss; Sudhir Srivastava; David C Ward; Zhen Zhang; Claire S Zhu; Nicole Urban
Journal:  Cancer Prev Res (Phila)       Date:  2011-03

3.  Cancer screening trials: nuts and bolts.

Authors:  Philip C Prorok; Pamela M Marcus
Journal:  Semin Oncol       Date:  2010-06       Impact factor: 4.929

4.  Cumulative incidence of false-positive results in repeated, multimodal cancer screening.

Authors:  Jennifer Miller Croswell; Barnett S Kramer; Aimee R Kreimer; Phil C Prorok; Jian-Lun Xu; Stuart G Baker; Richard Fagerstrom; Thomas L Riley; Jonathan D Clapp; Christine D Berg; John K Gohagan; Gerald L Andriole; David Chia; Timothy R Church; E David Crawford; Mona N Fouad; Edward P Gelmann; Lois Lamerato; Douglas J Reding; Robert E Schoen
Journal:  Ann Fam Med       Date:  2009 May-Jun       Impact factor: 5.166

5.  Genetic Variants of CLPP and M1AP Are Associated With Risk of Non-Small Cell Lung Cancer.

Authors:  Xianghan Li; Yiran Zou; Teng Li; Thomas K F Wong; Ryan T Bushey; Michael J Campa; Elizabeth B Gottlin; Hongliang Liu; Qingyi Wei; Allen Rodrigo; Edward F Patz
Journal:  Front Oncol       Date:  2021-09-15       Impact factor: 6.244

6.  Recruitment to multicentre trials--lessons from UKCTOCS: descriptive study.

Authors:  Usha Menon; Aleksandra Gentry-Maharaj; Andy Ryan; Aarti Sharma; Matthew Burnell; Rachel Hallett; Sara Lewis; Alberto Lopez; Keith Godfrey; David Oram; Jonathan Herod; Karin Williamson; Mourad Seif; Ian Scott; Tim Mould; Robert Woolas; John Murdoch; Stephen Dobbs; Nazar Amso; Simon Leeson; Derek Cruickshank; Ali McGuire; Stuart Campbell; Lesley Fallowfield; Steve Skates; Mahesh Parmar; Ian Jacobs
Journal:  BMJ       Date:  2008-11-13

7.  Evaluation of Oxidative Stress Response Related Genetic Variants, Pro-oxidants, Antioxidants and Prostate Cancer.

Authors:  Nicole Lavender; David W Hein; Guy Brock; La Creis R Kidd
Journal:  AIMS Med Sci       Date:  2015-09-10

8.  Calcium: magnesium intake ratio and colorectal carcinogenesis, results from the prostate, lung, colorectal, and ovarian cancer screening trial.

Authors:  Jing Zhao; Ayush Giri; Xiangzhu Zhu; Martha J Shrubsole; Yixing Jiang; Xingyi Guo; Reid Ness; Douglas L Seidner; Edward Giovannucci; Todd L Edwards; Qi Dai
Journal:  Br J Cancer       Date:  2019-09-23       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.